A neuromuscular‐based analysis of the open payments program

In August 2013, the Centers for Medicare and Medicaid Services (CMS) Open Payments Program (OPP) made eligible payment information publicly available. Data about industry payments to neuromuscular neurologists are lacking.

[1]  S. Khadilkar,et al.  Chronic immune polyradiculopathies: Three clinical variants of one disease? , 2020, Muscle & nerve.

[2]  Krishna Nalleballe,et al.  Abstract WMP96: Industry Payments to Vascular Neurologists, a Six-Year Analysis of the Open Payments Program From 2013 to 2018 , 2020, Stroke.

[3]  Poornachand Veerapaneni,et al.  Industry Payment to Vascular Neurologists , 2019, Stroke.

[4]  K. Murugiah,et al.  Industry Payments to Cardiologists: An Analysis of the Open Payments Program From 2014 to 2016 , 2018, Circulation. Cardiovascular quality and outcomes.

[5]  P. Narayanaswami,et al.  Financial relationships between neurologists and industry , 2018, Neurology.

[6]  Michael L. Johnson,et al.  Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data , 2018, BMC Health Services Research.

[7]  Omid Moshtaghi,et al.  An Analysis of the Open Payment Database in Neurotology , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[8]  H. Krumholz,et al.  Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study , 2016, British Medical Journal.

[9]  Grace A Lin,et al.  Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. , 2016, JAMA internal medicine.

[10]  P. Budetti,et al.  The Sunshine Act--effects on physicians. , 2013, The New England journal of medicine.

[11]  L. Bero.  Industry sponsorship and research outcome: a Cochrane review. , 2013, JAMA internal medicine.

[12]  Ray Moynihan,et al.  Key opinion leaders: independent experts or drug representatives in disguise? , 2008, BMJ : British Medical Journal.

[13]  David Blumenthal,et al.  A national survey of physician-industry relationships. , 2007, The New England journal of medicine.

[14]  Jordan J. Cohen,et al.  Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. , 2006, JAMA.

[15]  L. Barozzi,et al.  Medical Professionalism in the New Millennium: A Physician Charter , 2002, Annals of Internal Medicine.